This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ashkenazi A, Pai RC, Fong S et al (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104: 155–162. doi:10.1172/JCI6926AshkenaziAPaiRCFongS1999Safety and antitumor activity of recombinant soluble Apo2 ligand10415516210.1172/JCI6926Open DOISearch in Google Scholar
Azijli K, Weyhenmeyer B, Peters GJ et al (2013) Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: Discord in the death receptor family. Cell Death Differ 20: 858–868. doi:10.1038/cdd.2013.28AzijliKWeyhenmeyerBPetersGJ2013Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: Discord in the death receptor family2085886810.1038/cdd.2013.28Open DOISearch in Google Scholar
Bai B, Chen H (2021) Metformin: A novel weapon against inflammation. Front Pharmacol 12:622262. doi: 10.3389/fphar.2021.622262BaiBChenH2021Metformin: A novel weapon against inflammation1262226210.3389/fphar.2021.622262Open DOISearch in Google Scholar
Bavi P, Prabhakaran SE, Abubaker J et al (2010) Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations. Mol Cancer 9:203. doi:10.1186/1476-4598-9-203BaviPPrabhakaranSEAbubakerJ2010Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations920310.1186/1476-4598-9-203Open DOISearch in Google Scholar
Berlec A, Završnik J, Butinar M et al (2015) In vivo imaging of Lactococcus lactis, Lactobacillus plantarum and Escherichia coli expressing infrared fluorescent protein in mice. Microb Cell Fact 14:181. doi:10.1186/s12934-015-0376-4BerlecAZavršnikJButinarM2015In vivo imaging of Lactococcus lactis, Lactobacillus plantarum and Escherichia coli expressing infrared fluorescent protein in mice1418110.1186/s12934-015-0376-4Open DOISearch in Google Scholar
Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301:527–530. doi:10.1038/301527a0BosmaGCCusterRPBosmaMJ1983A severe combined immunodeficiency mutation in the mouse30152753010.1038/301527a0Open DOISearch in Google Scholar
Bosma M (1991) The scid mouse mutant: Definition, characterization, and potential uses. Annu Rev Immunol 9:323–350. doi:10.1146/annurev.immunol.9.1.323BosmaM1991The scid mouse mutant: Definition, characterization, and potential uses932335010.1146/annurev.immunol.9.1.323Open DOISearch in Google Scholar
Carvalho RD, Breyner N, Menezes-Garcia Z et al (2017) Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis. Microb Cell Fact 16:27. doi:10.1186/s12934-017-0624-xCarvalhoRDBreynerNMenezes-GarciaZ2017Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis162710.1186/s12934-017-0624-xOpen DOISearch in Google Scholar
Ciaćma K, Wiȩckiewicz J, Kȩdracka-Krok S et al (2018) Secretion of tumoricidal human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by recombinant Lactococcus lactis: Optimization of in vitro synthesis conditions. Microb Cell Fact 17:177. doi:10.1186/s12934-018-1028-2CiaćmaKWiȩckiewiczJKȩdracka-KrokS2018Secretion of tumoricidal human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by recombinant Lactococcus lactis: Optimization of in vitro synthesis conditions1717710.1186/s12934-018-1028-2Open DOISearch in Google Scholar
Cummins JM, Kohli M, Rago C et al (2004) X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res 64:3006–3008. doi:10.1158/0008-5472.CAN-04-0046CumminsJMKohliMRagoC2004X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells643006300810.1158/0008-5472.CAN-04-0046Open DOISearch in Google Scholar
DeRoche TC, Xiao SY, Liu X (2014) Histological evaluation in ulcerative colitis. Gastroenterol Rep 2:178–192. doi:10.1093/gastro/gou031DeRocheTCXiaoSYLiuX2014Histological evaluation in ulcerative colitis217819210.1093/gastro/gou031Open DOISearch in Google Scholar
Dinh CHL, Yu Y, Szabo A et al (2016) Bardoxolone methyl prevents high-fat diet-induced colon inflammation in mice. J Histochem Cytochem 64:237–255. doi:10.1369/0022155416631803DinhCHLYuYSzaboA2016Bardoxolone methyl prevents high-fat diet-induced colon inflammation in mice6423725510.1369/0022155416631803Open DOISearch in Google Scholar
Ehrhardt H, Fulda S, Schmid I et al (2003) TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB. Oncogene 22:3842–3852. doi:10.1038/sj.onc.1206520EhrhardtHFuldaSSchmidI2003TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB223842385210.1038/sj.onc.1206520Open DOISearch in Google Scholar
Evans JP, Sutton PA, Winiarski BK et al (2016) From mice to men: Murine models of colorectal cancer for use in translational research. Crit Rev Oncol Hematol 98:94–105. doi:10.1016/j.critrevonc.2015.10.009EvansJPSuttonPAWiniarskiBK2016From mice to men: Murine models of colorectal cancer for use in translational research989410510.1016/j.critrevonc.2015.10.009Open DOISearch in Google Scholar
Galligan L, Longley DB, McEwan M et al (2005) Chemotherapy and TRAIL-mediated colon cancer cell death: The roles of p53, TRAIL receptors, and c-FLIP. Mol Cancer Ther 4:2026–2036. doi:10.1158/1535-7163.MCT-05-0262GalliganLLongleyDBMcEwanM2005Chemotherapy and TRAIL-mediated colon cancer cell death: The roles of p53, TRAIL receptors, and c-FLIP42026203610.1158/1535-7163.MCT-05-0262Open DOISearch in Google Scholar
Ganten TM, Sykora J, Koschny R et al (2009) Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer. J Mol Med 87:995–1007. doi:10.1007/s00109-009-0510-zGantenTMSykoraJKoschnyR2009Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer87995100710.1007/s00109-009-0510-zOpen DOISearch in Google Scholar
Guilbaud N, Kraus-Berthier L, Meyer-Losic F et al (2001) Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors. Clin Cancer Res 7:2573–2580GuilbaudNKraus-BerthierLMeyer-LosicF2001Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors725732580Search in Google Scholar
Hartwig T, Montinaro A, von Karstedt S et al (2017) The TRAIL-induced cancer secretome promotes a tumor-supportive immune microenvironment via CCR2. Mol Cell 65:730–742.e5. doi:10.1016/j.molcel.2017.01.021HartwigTMontinaroAvon KarstedtS2017The TRAIL-induced cancer secretome promotes a tumor-supportive immune microenvironment via CCR265730742.e510.1016/j.molcel.2017.01.021Open DOISearch in Google Scholar
Herbst RS, Eckhardt SG, Kurzrock R et al (2010) Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer. J Clin Oncol 28:2839–2846. doi:10.1200/JCO.2009.25.1991HerbstRSEckhardtSGKurzrockR2010Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer282839284610.1200/JCO.2009.25.1991Open DOISearch in Google Scholar
Hernandez A, Wang Q, Schwartz SA et al (2001) Sensitization of human colon cancer cells to TRAIL-mediated apoptosis. J Gastrointest Surg 5:56–65. doi:10.1016/S1091-255X(01)80014-7HernandezAWangQSchwartzSA2001Sensitization of human colon cancer cells to TRAIL-mediated apoptosis5566510.1016/S1091-255X(01)80014-7Open DOISearch in Google Scholar
Hosono K, Endo H, Takahashi H et al (2010) Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial. Cancer Prev Res 3:1077–1083. doi: 10.1158/1940-6207HosonoKEndoHTakahashiH2010Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial31077108310.1158/1940-6207Open DOISearch in Google Scholar
Jin Z, McDonald ER, Dicker DT et al (2004) Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. J Biol Chem 279:35829–35839. doi:10.1074/jbc.M405538200JinZMcDonaldERDickerDT2004Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis279358293583910.1074/jbc.M405538200Open DOISearch in Google Scholar
Kaczmarek K, Więckiewicz J, Węglarczyk K et al. (2021) The anti-tumor effect of lactococcus lactis bacteria-secreting human soluble trail can be enhanced by metformin both in vitro and in vivo in a mouse model of human colorectal cancer. Cancers 13:3004. doi:10.3390/cancers13123004KaczmarekKWięckiewiczJWęglarczykK2021The anti-tumor effect of lactococcus lactis bacteria-secreting human soluble trail can be enhanced by metformin both in vitro and in vivo in a mouse model of human colorectal cancer13300410.3390/cancers13123004Open DOISearch in Google Scholar
Kaler P, Augenlicht L, Klampfer L (2009) Macrophage-derived IL-1B stimulates Wnt signaling and growth of colon cancer cells: A crosstalk interrupted by vitamin D”3. Oncogene 28:3892–3902. doi:10.1038/onc.2009.247KalerPAugenlichtLKlampferL2009Macrophage-derived IL-1B stimulates Wnt signaling and growth of colon cancer cells: A crosstalk interrupted by vitamin D”3283892390210.1038/onc.2009.247Open DOISearch in Google Scholar
Kaler P, Galea V, Augenlicht L et al (2010) Tumor associated macrophages protect colon cancer cells from TRAIL-induced apoptosis through IL-1β-dependent stabilization of snail in tumor cells. PLoS One 5:e11700. doi:10.1371/journal.pone.0011700KalerPGaleaVAugenlichtL2010Tumor associated macrophages protect colon cancer cells from TRAIL-induced apoptosis through IL-1β-dependent stabilization of snail in tumor cells5e1170010.1371/journal.pone.0011700Open DOISearch in Google Scholar
Kamarudin MNA, Sarker MMR, Zhou JR et al (2019) Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects. J Exp Clin Cancer Res 38:491. doi: 10.1186/s13046-019-1495-2.KamarudinMNASarkerMMRZhouJR2019Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects3849110.1186/s13046-019-1495-2Open DOISearch in Google Scholar
Kelley SK, Harris LA, Xie D et al (2001) Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: Characterization of in vivo efficacy, pharmacokinetics, and safety. J Pharmacol Exp Ther 299:31–38KelleySKHarrisLAXieD2001Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: Characterization of in vivo efficacy, pharmacokinetics, and safety2993138Search in Google Scholar
Klijn N, Weerkamp AH, De Vos WM (1995) Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl Environ Microbiol 61:2771–2774. doi:10.1128/aem.61.7.2771-2774.1995KlijnNWeerkampAHDe VosWM1995Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract612771277410.1128/aem.61.7.2771-2774.1995Open DOISearch in Google Scholar
Kos B, Šušković J, Goreta J et al (2000) Effect of protectors on the viability of Lactobacillus acidophilus M92 in simulated gastrointestinal conditions. Food Technol Biotechnol 38:121–127KosBŠuškovićJGoretaJ2000Effect of protectors on the viability of Lactobacillus acidophilus M92 in simulated gastrointestinal conditions38121127Search in Google Scholar
Lemke J, Von Karstedt S, Zinngrebe J et al (2014) Getting TRAIL back on track for cancer therapy. Cell Death Differ 21: 1350–1364. doi:10.1038/cdd.2014.81LemkeJVon KarstedtSZinngrebeJ2014Getting TRAIL back on track for cancer therapy211350136410.1038/cdd.2014.81Open DOISearch in Google Scholar
Lin Y, Xu J, Lan H (2019) Tumor-associated macrophages in tumor metastasis: Biological roles and clinical therapeutic applications. J Hematol Oncol 12:76. doi:10.1186/s13045-019-0760-3LinYXuJLanH2019Tumor-associated macrophages in tumor metastasis: Biological roles and clinical therapeutic applications127610.1186/s13045-019-0760-3Open DOISearch in Google Scholar
Ma W, Chen J, Meng Y et al (2018) Metformin alters gut microbiota of healthy mice: Implication for its potential role in gut microbiota homeostasis. Front Microbiol 9:1336. doi:10.3389/fmicb.2018.01336MaWChenJMengY2018Metformin alters gut microbiota of healthy mice: Implication for its potential role in gut microbiota homeostasis9133610.3389/fmicb.2018.01336Open DOISearch in Google Scholar
Mantovani A, Sica A, Sozzani S et al (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677–686. doi:10.1016/j.it.2004.09.015MantovaniASicaASozzaniS2004The chemokine system in diverse forms of macrophage activation and polarization2567768610.1016/j.it.2004.09.015Open DOISearch in Google Scholar
Molloy AM, Ardill J, Tomkin GH (1980) The effect of metformin treatment on gastric acid secretion and gastrointestinal hormone levels in normal subjects. Diabetologia 19:93–96. doi:10.1007/BF00421851MolloyAMArdillJTomkinGH1980The effect of metformin treatment on gastric acid secretion and gastrointestinal hormone levels in normal subjects19939610.1007/BF00421851Open DOISearch in Google Scholar
Ozawa F, Friess H, Kleeff J et al (2001) Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer. Cancer Lett 163:71–81. doi:10.1016/S0304-3835(00)00660-1OzawaFFriessHKleeffJ2001Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer163718110.1016/S0304-3835(00)00660-1Open DOISearch in Google Scholar
Park SH, Lee DH, Kim JL et al (2016) Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells. Oncotarget 7:59503–59518. doi:10.18632/oncotarget.11147ParkSHLeeDHKimJL2016Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells7595035951810.18632/oncotarget.11147Open DOISearch in Google Scholar
Pitti RM, Marsters SA, Ruppert S et al (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271:12687–12690. doi:10.1074/jbc.271.22.12687PittiRMMarstersSARuppertS1996Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family271126871269010.1074/jbc.271.22.12687Open DOISearch in Google Scholar
Saturno G, Valenti M, De Haven Brandon A et al (2013) Combining TRAIL with PI3 kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling. Oncotarget 4:1185–1198. doi:10.18632/oncotarget.1162SaturnoGValentiMDe Haven BrandonA2013Combining TRAIL with PI3 kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling41185119810.18632/oncotarget.1162Open DOISearch in Google Scholar
Takayama T, Katsuki S, Takahashi Y et al (1998) Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 339:1277–1284. doi: 10.1056/NEJM199810293391803TakayamaTKatsukiSTakahashiY1998Aberrant crypt foci of the colon as precursors of adenoma and cancer3391277128410.1056/NEJM199810293391803Open DOISearch in Google Scholar
Van Dijk M, Halpin-McCormick A, Sessler T et al (2013) Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways. Cell Death Dis 4:e702. doi:10.1038/cddis.2013.214Van DijkMHalpin-McCormickASesslerT2013Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways4e70210.1038/cddis.2013.214Open DOISearch in Google Scholar
Varfolomeev E, Maecker H, Sharp D et al (2005) Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand. J Biol Chem 280:40599–40608. doi:10.1074/jbc.M509560200VarfolomeevEMaeckerHSharpD2005Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand280405994060810.1074/jbc.M509560200Open DOISearch in Google Scholar
von Karstedt S, Conti A, Nobis M et al (2015) Cancer cell-autonomous TRAIL-R signaling promotes KRAS-Driven cancer progression, invasion, and metastasis. Cancer Cell 27:561–573. doi:10.1016/j.ccell.2015.02.014von KarstedtSContiANobisM2015Cancer cell-autonomous TRAIL-R signaling promotes KRAS-Driven cancer progression, invasion, and metastasis2756157310.1016/j.ccell.2015.02.014Open DOISearch in Google Scholar
Wang LX, Zhang SX, Wu HJ et al (2019) M2b macrophage polarization and its roles in diseases. J Leukoc Biol 106:345–358. doi:10.1002/JLB.3RU1018-378RRWangLXZhangSXWuHJ2019M2b macrophage polarization and its roles in diseases10634535810.1002/JLB.3RU1018-378RROpen DOISearch in Google Scholar
Wiley SR, Schooley K, Smolak PJ et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673–682. doi:10.1016/1074-7613(95)90057-8WileySRSchooleyKSmolakPJ1995Identification and characterization of a new member of the TNF family that induces apoptosis367368210.1016/1074-7613(95)90057-8Open DOISearch in Google Scholar
Wu H, Esteve E, Tremaroli V et al (2017) Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med 23:850–858. doi:10.1038/nm.4345WuHEsteveETremaroliV2017Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug2385085810.1038/nm.4345Open DOISearch in Google Scholar
Zhang Y, Davis C, Ryan J et al (2013) Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver. Clin Exp Metastasis 30:903–918. doi:10.1007/s10585-013-9591-8ZhangYDavisCRyanJ2013Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver3090391810.1007/s10585-013-9591-8Open DOISearch in Google Scholar
Zhao X, Li L, Starr TK et al (2017) Tumor location impacts immune response in mouse models of colon cancer. Oncotarget 8:54775–54787. doi:10.18632/oncotarget.18423ZhaoXLiLStarrTK2017Tumor location impacts immune response in mouse models of colon cancer8547755478710.18632/oncotarget.18423Open DOISearch in Google Scholar